Fig. 4.
Disease-free survival.
(A) Comparison of disease-free survival following allogeneic transplantation of peripheral blood stem cells (PBSCT) or bone marrow (BMT). (B) Comparison of disease-free survival using landmark analysis among patients surviving beyond day 100.